An FDA advisory committee of independent experts recently voted 15 to
8 to add a “black box” warning to the packaging information of
all antidepressants concerning the risk of increased suicidal tendencies in
children and adolescents. Following review, the FDA stated that it “generally
supports the recommendations” of the advisory committee (http://www.fda.gov/bbs/topics/news/2004/NEW01116.html).
Hampton T. Antidepressant Warnings. JAMA. 2004;292(16):1946. doi:https://doi.org/10.1001/jama.292.16.1946-d
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: